UB Paderborn / Katalog / Suche / in CDI

1 – 16 von 16

Sortiert nach

VISTA is an acidic pH-selective ligand for PSGL-1

Nature (London), 2019-10, Vol.574 (7779), p.565-570

2019

Volltextzugriff (PDF)

Parkinson's disease protein α-synuclein disrupts cellular Rab homeostasis

Proceedings of the National Academy of Sciences - PNAS, 2008-01, Vol.105 (1), p.145-150

2008

Volltextzugriff (PDF)

Bridging high-throughput genetic and transcriptional data reveals cellular responses to alpha-synuclein toxicity

Nature genetics, 2009-03, Vol.41 (3), p.316-323

2009

Volltextzugriff (PDF)

Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models

Disease models & mechanisms, 2010-03, Vol.3 (3-4), p.194-208

2010

Volltextzugriff (PDF)

Dual Inhibition of Interleukin-23 and Interleukin-17 Offers Superior Efficacy in Mouse Models of Autoimmunity

The Journal of pharmacology and experimental therapeutics, 2015-08, Vol.354 (2), p.152

2015

Volltextzugriff (PDF)

An obligate intermediate along the slow folding pathway of a group II intron ribozyme

Nucleic acids research, 2005-01, Vol.33 (21), p.6674

2005

Volltextzugriff (PDF)

Direct and selective elimination of specific prions and amyloids by 4,5-dianilinophthalimide and analogs

Proceedings of the National Academy of Sciences - PNAS, 2008-05, Vol.105 (20), p.7159-7164

2008

Volltextzugriff (PDF)

Visualizing the solvent-inaccessible core of a group II intron ribozyme

The EMBO journal, 2001-04, Vol.20 (8), p.2051-2061

2001

Volltextzugriff (PDF)

Group II introns: highly specific endonucleases with modular structures and diverse catalytic functions

Methods (San Diego, Calif.), 2002-11, Vol.28 (3), p.323-335

2002

Volltextzugriff (PDF)

Abstract 1548: Acidic pH selective binding of VISTA to PSGL-1 and anti-tumor activity of combined VISTA and PD-1 blockade

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.1548-1548

2019

Volltextzugriff (PDF)

An Alternative Route for the Folding of Large RNAs: Apparent Two-state Folding by a Group II Intron Ribozyme

Journal of molecular biology, 2003-12, Vol.334 (4), p.639-652

2003

Volltextzugriff (PDF)

Bridging high-throughput genetic and transcriptional data reveals cellular responses to alphα-synuclein toxicity

Nature genetics, 2009-03, Vol.41 (3), p.316

2009

Volltextzugriff (PDF)

Bridging the gap between high-throughput genetic and transcriptional data reveals cellular pathways responding to alpha-synuclein toxicity

Nature genetics, 2009-02, Vol.41 (3), p.316-323

2009

Volltextzugriff (PDF)

The Parkinson's disease protein ¿-synuclein disrupts cellular Rab homeostasis

Proceedings of the National Academy of Sciences - PNAS, 2008-01, Vol.105 (1), p.145

2008

Volltextzugriff (PDF)

Guiding ribozyme cleavage through motif recognition: the mechanism of cleavage site selection by a group II intron ribozyme

Journal of molecular biology, 2001-03, Vol.306 (4), p.655-668

2001

Volltextzugriff (PDF)

Chapter 38 - Yeast Cells as a Discovery Platform for Parkinson's Disease and other Protein Misfolding Diseases

Parkinson's Disease, 2008, p.505-536

2008

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(12)

Publikationsform

Artikel
(15)
Buchkapitel
(1)

Sprache

Englisch
(16)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

VISTA is an acidic pH-selective ligand for PSGL-1

Parkinson's disease protein α-synuclein disrupts cellular Rab homeostasis

Bridging high-throughput genetic and transcriptional data reveals cellular responses to alpha-synuclein toxicity

Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models

Dual Inhibition of Interleukin-23 and Interleukin-17 Offers Superior Efficacy in Mouse Models of Autoimmunity

An obligate intermediate along the slow folding pathway of a group II intron ribozyme

Direct and selective elimination of specific prions and amyloids by 4,5-dianilinophthalimide and analogs

Visualizing the solvent-inaccessible core of a group II intron ribozyme

Group II introns: highly specific endonucleases with modular structures and diverse catalytic functions

Abstract 1548: Acidic pH selective binding of VISTA to PSGL-1 and anti-tumor activity of combined VISTA and PD-1 blockade

An Alternative Route for the Folding of Large RNAs: Apparent Two-state Folding by a Group II Intron Ribozyme

Bridging high-throughput genetic and transcriptional data reveals cellular responses to alphα-synuclein toxicity

Bridging the gap between high-throughput genetic and transcriptional data reveals cellular pathways responding to alpha-synuclein toxicity

The Parkinson's disease protein ¿-synuclein disrupts cellular Rab homeostasis

Guiding ribozyme cleavage through motif recognition: the mechanism of cleavage site selection by a group II intron ribozyme

Chapter 38 - Yeast Cells as a Discovery Platform for Parkinson's Disease and other Protein Misfolding Diseases

Suchergebnisse filtern